Integrin triplets of marine sponges in human D2 receptor heteromers

References

• Agnati LF, Guidolin D, Albertin G, Trivello E, Ciruela F, Genedani S, Tarakanov A, Fuxe K. An integrated view on the role of receptor mosaics at perisynaptic level: Focus on adenosine A(2A), dopamine D(2), cannabinoid CB(1), and metabotropic glutamate mGlu(5) receptors. J Recept Signal Transduct Res 2010, 30, 355–369.
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124, 783–801.
   PubMed Web of Science ®Google Scholar
• Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Marcellino D, Ciruela F, Agnati LF, Fuxe K. Dopamine D2 and 5-hydroxytryptamine 5-HT(2A) receptors assemble into functionally interacting heteromers. Biochem Biophys Res Commun 2010, 401, 605–610.
   PubMedGoogle Scholar
• Borroto-Escuela DO, Narvaez M, Marcellino D, Parrado C, Narvaez JA, Tarakanov AO, Agnati LF, Díaz-Cabiale Z, Fuxe K. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochem Biophys Res Commun 2010, 393, 767–772.
   PubMed Web of Science ®Google Scholar
• Borroto-Escuela DO, Tarakanov AO, Guidolin D, Ciruela F, Agnati LF, Fuxe K. Moonlighting characteristics of G protein-coupled receptors: Focus on receptor heteromers and relevance for neurodegeneration. IUBMB Life 2011, 63, 463–472.
   PubMedGoogle Scholar
• Borroto-Escuela DO, Van Craenenbroeck K, Romero-Fernandez W, Guidolin D, Woods AS, Rivera A, Haegeman G, Agnati LF, Tarakanov AO, Fuxe K. Dopamine D2 and D4 receptor heteromerization and its allosteric receptor-receptor interactions. Biochem Biophys Res Commun 2011, 404, 928–934.
   PubMed Web of Science ®Google Scholar
• Borroto-Escuela DO, Romero-Fernandez W, Mudó G, Pérez-Alea M, Ciruela F, Tarakanov AO, Narvaez M, Di Liberto V, Agnati LF, Belluardo N, Fuxe K. Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity. Biol Psychiatry 2012, 71, 84–91.
   PubMed Web of Science ®Google Scholar
• Borroto-Escuela DO, Romero-Fernandez W, Pérez-Alea M, Narvaez M, Tarakanov AO, Mudó G, Agnati LF, Ciruela F, Belluardo N, Fuxe K. The Existence of FGFR1-5-HT1A Receptor Heterocomplexes in Midbrain 5-HT Neurons of the Rat: Relevance for Neuroplasticity. J Neurosci 2012, 32, 6295–6303.
   PubMedGoogle Scholar
• Buljan M, Bateman A. The evolution of protein domain families. Biochem Soc Trans 2009, 37, 751–755.
   PubMed Web of Science ®Google Scholar
• Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, Ferré S, Lluis C, Bouvier M, Franco R. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 2003, 278, 46741–46749.
   PubMed Web of Science ®Google Scholar
• Dasgupta S, Li XM, Jansson A, Finnman UB, Matsui T, Rinken A, Arenas E, Agnati LF, Fuxe K. Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs. Brain Res Mol Brain Res 1996, 36, 292–299.
   PubMedGoogle Scholar
• Dunham JH, Meyer RC, Garcia EL, Hall RA. GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions. Biochemistry 2009, 48, 10286–10297.
   PubMedGoogle Scholar
• Faraone D, Aguzzi MS, Ragone G, Russo K, Capogrossi MC, Facchiano A. Heterodimerization of FGF-receptor 1 and PDGF-receptor-α: A novel mechanism underlying the inhibitory effect of PDGF-BB on FGF-2 in human cells. Blood 2006, 107, 1896–1902.
   PubMedGoogle Scholar
• Ferrada C, Ferré S, Casadó V, Cortés A, Justinova Z, Barnes C, Canela EI, Goldberg SR, Leurs R, Lluis C, Franco R. Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 2008, 55, 190–197.
   PubMed Web of Science ®Google Scholar
• Fuxe K, Canals M, Torvinen M, Marcellino D, Terasmaa A, Genedani S, Leo G, Guidolin D, Diaz-Cabiale Z, Rivera A, Lundstrom L, Langel U, Narvaez J, Tanganelli S, Lluis C, Ferré S, Woods A, Franco R, Agnati LF. Intramembrane receptor-receptor interactions: A novel principle in molecular medicine. J Neural Transm 2007, 114, 49–75.
   PubMed Web of Science ®Google Scholar
• Fuxe K, Borroto-Escuela DO, Marcellino D, Romero-Fernandez W, Frankowska M, Guidolin D, Filip M, Ferraro L, Woods AS, Tarakanov A, Ciruela F, Agnati LF, Tanganelli S. GPCR heteromers and their allosteric receptor-receptor interactions. Curr Med Chem 2012, 19, 356–363.
   PubMedGoogle Scholar
• Gamulin V, Rinkevich B, Schäcke H, Kruse M, Müller IM, Müller WE. Cell adhesion receptors and nuclear receptors are highly conserved from the lowest metazoa (marine sponges) to vertebrates. Biol Chem Hoppe-Seyler 1994, 375, 583–588.
   PubMedGoogle Scholar
• González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, Milligan G, Gingrich JA, Filizola M, Meana JJ, Sealfon SC. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008, 452, 93–97.
   PubMed Web of Science ®Google Scholar
• González S, Rangel-Barajas C, Peper M, Lorenzo R, Moreno E, Ciruela F, Borycz J, Ortiz J, Lluís C, Franco R, McCormick PJ, Volkow ND, Rubinstein M, Floran B, Ferré S. Dopamine D(4) receptor, but not the ADHD-associated D(4.7) variant, forms functional heteromers with the dopamine D(2S) receptor in the brain. Mol Psych 2011, 7, 1–13.
   Google Scholar
• Guyon A, Nahon JL. Multiple actions of the chemokine stromal cell-derived factor-1α on neuronal activity. J Mol Endocrinol 2007, 38, 365–376.
   PubMedGoogle Scholar
• Hague C, Lee SE, Chen Z, Prinster SC, Hall RA, Minneman KP. Heterodimers of α1B- and α1D-adrenergic receptors form a single functional entity. Mol Pharmacol 2006, 69, 45–55.
   PubMedGoogle Scholar
• Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 1996, 93, 497–501.
   PubMed Web of Science ®Google Scholar
• Hirono M, Yoshioka T, Konishi S. GABA(B) receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses. Nat Neurosci 2001, 4, 1207–1216.
   PubMedGoogle Scholar
• Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007, 130, 1071–1082.
   PubMed Web of Science ®Google Scholar
• Kearn CS, Blake-Palmer K, Daniel E, Mackie K, Glass M. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk? Mol Pharmacol 2005, 67, 1697–1704.
   PubMed Web of Science ®Google Scholar
• Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001, 11, 725–732.
   PubMed Web of Science ®Google Scholar
• Landschulz WH, Johnson PF, McKnight SL. The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins. Science 1988, 240, 1759–1764.
   PubMed Web of Science ®Google Scholar
• Lee SP, O’Dowd BF, Rajaram RD, Nguyen T, George SR. D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry 2003, 42, 11023–11031.
   PubMed Web of Science ®Google Scholar
• Lee SP, So CH, Rashid AJ, Varghese G, Cheng R, Lança AJ, O’Dowd BF, George SR. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 2004, 279, 35671–35678.
   PubMed Web of Science ®Google Scholar
• Liu XY, Chu XP, Mao LM, Wang M, Lan HX, Li MH, Zhang GC, Parelkar NK, Fibuch EE, Haines M, Neve KA, Liu F, Xiong ZG, Wang JQ. Modulation of D2R-NR2B interactions in response to cocaine. Neuron 2006, 52, 897–909.
   PubMed Web of Science ®Google Scholar
• Lukasiewicz S, Polit A, Kedracka-Krok S, Wedzony K, Mackowiak M, Dziedzicka-Wasylewska M. Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors. Biochim Biophys Acta 2010, 1803, 1347–1358.
   PubMed Web of Science ®Google Scholar
• Lukasiewicz S, Faron-Górecka A, Kedracka-Krok S, Dziedzicka-Wasylewska M. Effect of clozapine on the dimerization of serotonin 5-HT(2A) receptor and its genetic variant 5-HT(2A)H425Y with dopamine D(2) receptor. Eur J Pharmacol 2011, 659, 114–123.
   PubMedGoogle Scholar
• Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 2008, 54, 815–823.
   PubMedGoogle Scholar
• Marshall FH, Jones KA, Kaupmann K, Bettler B. GABAB receptors – the first 7TM heterodimers. Trends Pharmacol Sci 2001, 20, 396–399.
   Google Scholar
• Mizuno T, Zhang G, Takeuchi H, Kawanokuchi J, Wang J, Sonobe Y, Jin S, Takada N, Komatsu Y, Suzumura A. Interferon-γ directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-γ receptor and AMPA GluR1 receptor. FASEB J 2008, 22, 1797–1806.
   PubMed Web of Science ®Google Scholar
• Muller WEG. Origin of metazoan adhesion molecules and adhesion receptors as deduced from cDNA analyses in the marine sponge Geodia cydonium: A review. Cell Tissue Res 1997, 289, 383–395.
   PubMed Web of Science ®Google Scholar
• Pancer Z, Kruse M, Müller I, Müller WE. On the origin of Metazoan adhesion receptors: Cloning of integrin α subunit from the sponge Geodia cydonium. Mol Biol Evol 1997, 14, 391–398.
   PubMed Web of Science ®Google Scholar
• Popoli P, Pèzzola A, Torvinen M, Reggio R, Pintor A, Scarchilli L, Fuxe K, Ferré S. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: Interactions with adenosine A(2a) receptors. Neuropsychopharmacology 2001, 25, 505–513.
   PubMed Web of Science ®Google Scholar
• Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 2000, 275, 7862–7869.
   PubMed Web of Science ®Google Scholar
• Romero-Fernandez W, Borroto-Escuela DO, Tarakanov AO, Mudó G, Narvaez M, Pérez-Alea M, Agnati LF, Ciruela F, Belluardo N, Fuxe K. Agonist-induced formation of FGFR1 homodimers and signaling differ among members of the FGF family. Biochem Biophys Res Commun 2011, 409, 764–768.
   PubMed Web of Science ®Google Scholar
• Scarselli M, Novi F, Schallmach E, Lin R, Baragli A, Colzi A, Griffon N, Corsini GU, Sokoloff P, Levenson R, Vogel Z, Maggio R. D2/D3 dopamine receptor heterodimers exhibit unique functional properties. J Biol Chem 2001, 276, 30308–30314.
   PubMed Web of Science ®Google Scholar
• So CH, Verma V, Alijaniaram M, Cheng R, Rashid AJ, O’Dowd BF, George SR. Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol Pharmacol 2009, 75, 843–854.
   PubMedGoogle Scholar
• Suzuki S, Chuang LF, Yau P, Doi RH, Chuang RY. Interactions of opioid and chemokine receptors: Oligomerization of mu, kappa, and delta with CCR5 on immune cells. Exp Cell Res 2002, 280, 192–200.
   PubMedGoogle Scholar
• Tarakanov AO, Fuxe KG, Agnati LF, Goncharova LB. Possible role of receptor heteromers in multiple sclerosis. J Neural Transm 2009, 116, 989–994.
   PubMedGoogle Scholar
• Tarakanov AO, Fuxe KG. Triplet puzzle: Homologies of receptor heteromers. J Mol Neurosci 2010, 41, 294–303.
   PubMed Web of Science ®Google Scholar
• Tarakanov AO, Fuxe KG. The triplet puzzle of homologies in receptor heteromers exists also in other types of protein-protein interactions. J Mol Neurosci 2011, 44, 173–177.
   PubMedGoogle Scholar
• Tarakanov AO, Fuxe KG, Borroto-Escuela DO. On the origin of the triplet puzzle of homologies in receptor heteromers: Immunoglobulin triplets in different types of receptors. J Mol Neurosci 2012, 46, 616–621.
   PubMedGoogle Scholar
• Tarakanov AO, Fuxe KG, Borroto-Escuela DO. On the origin of the triplet puzzle of homologies in receptor heteromers: Toll-like receptor triplets in different types of receptors. J Neural Transm 2012, 119, 517–523.
   PubMedGoogle Scholar
• von Euler G. Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain. Brain Res 1991, 561, 93–98.
   PubMedGoogle Scholar